Harmony Biosciences, LLC   Report issue

For profit Phase 3 Phase 4
Founded: Plymouth Meeting PA United States (2017)
Status: No NME R&D (2017)

Organization Overview

First Clinical Trial
2020
NCT04257929
First Marketed Drug
2019
pitolisant (Wakix)
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

HARMONY | Harmony Biosciences, LLC